New

Natural Killer Cells Therapeutics Market

2021

Natural Killer Cells Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapeutics (Natural killer Cell Therapies, Natural killer Cell Directed Antibodies); Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others); End User (Research Centers and Institutes, Hospitals, Others) and Geography

| Report Code: TIPRE00015768 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming

Market Insights

Natural Killer Cells Therapeutics Market 2028 By Therapeutics, Application, End User and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Natural killer cells are large granular lymphocytes that respond quickly to a pathological challenge. In addition, they are responsible for producing immunoregulatory cytokines. Moreover, they act as an important component of the innate immune system of a human. The key role of NK cells is to generate an immune response against malignancies and viral infections.

MARKET SCOPE

The "Global Natural killer cells therapeutics Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Natural killer cells therapeutics market with detailed market segmentation by therapeutics, application, end user and geography. The report provides key statistics on the market status of the leading Natural killer cells therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on therapeutics, the global Natural killer cells therapeutics market is segmented into NK Cell Therapies, NK Cell Directed Antibodies.
  •   Based on application, the market is categorised into Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others.
  •   Based on end user, the market is categorised into Research Centers and Institutes , Hospitals, Others.

MARKET DYNAMICS
Drivers:

  •   Rise in adoption of NK cells for the treatment of cancer, infections, and liver diseases.
  •   The rise in awareness among the population regarding various immunotherapies
  •   increase in R&D for the development of bi-specific antibody for engaging NK cells

Restraints:

  •   The lack of specificity and poor in-vivo survival of the cells limit the natural killer cells therapeutics.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Natural killer cells therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Natural killer cells therapeutics market in these regions.

IMPACT OF COVID-19 ON NATURAL KILLER CELLS THERAPEUTICSMARKET

The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the natural killer cell therapeutics market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all outdoor events restricted; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. All these factors will restrict the growth of the market due to pandemic.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the natural killer cells therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Natural killer cells therapeuticsmarket are anticipated to lucrative growth opportunities in the future with the rising demand for Natural killer cells therapeutics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Natural killer cells therapeutics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Affimed N.V.
  •   Celgene Corporation
  •   Fate Therapeutics
  •   Fortress Biotech
  •   Glycostem Therapeutics BV
  •   Innate Pharma S.A.
  •   Nantkwest Inc.
  •   Nkarta Therapeutics, Inc.
  •   EMERcell
  •   Ziopharm Oncology Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Natural Killer Cells Therapeutics Market - By Therapeutics
1.3.2 Natural Killer Cells Therapeutics Market - By Application
1.3.3 Natural Killer Cells Therapeutics Market - By End User
1.3.4 Natural Killer Cells Therapeutics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NATURAL KILLER CELLS THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NATURAL KILLER CELLS THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NATURAL KILLER CELLS THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. NATURAL KILLER CELLS THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. NATURAL KILLER CELLS THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. NATURAL KILLER CELLS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - THERAPEUTICS
7.1. OVERVIEW
7.2. THERAPEUTICS MARKET FORECASTS AND ANALYSIS
7.3. NATURAL KILLER CELL THERAPIES
7.3.1. Overview
7.3.2. Natural killer Cell Therapies Market Forecast and Analysis
7.4. NATURAL KILLER CELL DIRECTED ANTIBODIES
7.4.1. Overview
7.4.2. Natural killer Cell Directed Antibodies Market Forecast and Analysis
8. NATURAL KILLER CELLS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER
8.3.1. Overview
8.3.2. Cancer Market Forecast and Analysis
8.4. GASTROINTESTINAL DISEASES
8.4.1. Overview
8.4.2. Gastrointestinal Diseases Market Forecast and Analysis
8.5. IMMUNOPROLIFERATIVE DISORDERS
8.5.1. Overview
8.5.2. Immunoproliferative Disorders Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. NATURAL KILLER CELLS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. RESEARCH CENTERS AND INSTITUTES
9.3.1. Overview
9.3.2. Research Centers and Institutes Market Forecast and Analysis
9.4. HOSPITALS
9.4.1. Overview
9.4.2. Hospitals Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. NATURAL KILLER CELLS THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Natural Killer Cells Therapeutics Market Overview
10.1.2 North America Natural Killer Cells Therapeutics Market Forecasts and Analysis
10.1.3 North America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Therapeutics
10.1.4 North America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Application
10.1.5 North America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By End User
10.1.6 North America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Natural Killer Cells Therapeutics Market
10.1.6.1.1 United States Natural Killer Cells Therapeutics Market by Therapeutics
10.1.6.1.2 United States Natural Killer Cells Therapeutics Market by Application
10.1.6.1.3 United States Natural Killer Cells Therapeutics Market by End User
10.1.6.2 Canada Natural Killer Cells Therapeutics Market
10.1.6.2.1 Canada Natural Killer Cells Therapeutics Market by Therapeutics
10.1.6.2.2 Canada Natural Killer Cells Therapeutics Market by Application
10.1.6.2.3 Canada Natural Killer Cells Therapeutics Market by End User
10.1.6.3 Mexico Natural Killer Cells Therapeutics Market
10.1.6.3.1 Mexico Natural Killer Cells Therapeutics Market by Therapeutics
10.1.6.3.2 Mexico Natural Killer Cells Therapeutics Market by Application
10.1.6.3.3 Mexico Natural Killer Cells Therapeutics Market by End User
10.2. EUROPE
10.2.1 Europe Natural Killer Cells Therapeutics Market Overview
10.2.2 Europe Natural Killer Cells Therapeutics Market Forecasts and Analysis
10.2.3 Europe Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Therapeutics
10.2.4 Europe Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Application
10.2.5 Europe Natural Killer Cells Therapeutics Market Forecasts and Analysis - By End User
10.2.6 Europe Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Natural Killer Cells Therapeutics Market
10.2.6.1.1 Germany Natural Killer Cells Therapeutics Market by Therapeutics
10.2.6.1.2 Germany Natural Killer Cells Therapeutics Market by Application
10.2.6.1.3 Germany Natural Killer Cells Therapeutics Market by End User
10.2.6.2 France Natural Killer Cells Therapeutics Market
10.2.6.2.1 France Natural Killer Cells Therapeutics Market by Therapeutics
10.2.6.2.2 France Natural Killer Cells Therapeutics Market by Application
10.2.6.2.3 France Natural Killer Cells Therapeutics Market by End User
10.2.6.3 Italy Natural Killer Cells Therapeutics Market
10.2.6.3.1 Italy Natural Killer Cells Therapeutics Market by Therapeutics
10.2.6.3.2 Italy Natural Killer Cells Therapeutics Market by Application
10.2.6.3.3 Italy Natural Killer Cells Therapeutics Market by End User
10.2.6.4 Spain Natural Killer Cells Therapeutics Market
10.2.6.4.1 Spain Natural Killer Cells Therapeutics Market by Therapeutics
10.2.6.4.2 Spain Natural Killer Cells Therapeutics Market by Application
10.2.6.4.3 Spain Natural Killer Cells Therapeutics Market by End User
10.2.6.5 United Kingdom Natural Killer Cells Therapeutics Market
10.2.6.5.1 United Kingdom Natural Killer Cells Therapeutics Market by Therapeutics
10.2.6.5.2 United Kingdom Natural Killer Cells Therapeutics Market by Application
10.2.6.5.3 United Kingdom Natural Killer Cells Therapeutics Market by End User
10.2.6.6 Rest of Europe Natural Killer Cells Therapeutics Market
10.2.6.6.1 Rest of Europe Natural Killer Cells Therapeutics Market by Therapeutics
10.2.6.6.2 Rest of Europe Natural Killer Cells Therapeutics Market by Application
10.2.6.6.3 Rest of Europe Natural Killer Cells Therapeutics Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Natural Killer Cells Therapeutics Market Overview
10.3.2 Asia-Pacific Natural Killer Cells Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Therapeutics
10.3.4 Asia-Pacific Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Natural Killer Cells Therapeutics Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Natural Killer Cells Therapeutics Market
10.3.6.1.1 Australia Natural Killer Cells Therapeutics Market by Therapeutics
10.3.6.1.2 Australia Natural Killer Cells Therapeutics Market by Application
10.3.6.1.3 Australia Natural Killer Cells Therapeutics Market by End User
10.3.6.2 China Natural Killer Cells Therapeutics Market
10.3.6.2.1 China Natural Killer Cells Therapeutics Market by Therapeutics
10.3.6.2.2 China Natural Killer Cells Therapeutics Market by Application
10.3.6.2.3 China Natural Killer Cells Therapeutics Market by End User
10.3.6.3 India Natural Killer Cells Therapeutics Market
10.3.6.3.1 India Natural Killer Cells Therapeutics Market by Therapeutics
10.3.6.3.2 India Natural Killer Cells Therapeutics Market by Application
10.3.6.3.3 India Natural Killer Cells Therapeutics Market by End User
10.3.6.4 Japan Natural Killer Cells Therapeutics Market
10.3.6.4.1 Japan Natural Killer Cells Therapeutics Market by Therapeutics
10.3.6.4.2 Japan Natural Killer Cells Therapeutics Market by Application
10.3.6.4.3 Japan Natural Killer Cells Therapeutics Market by End User
10.3.6.5 South Korea Natural Killer Cells Therapeutics Market
10.3.6.5.1 South Korea Natural Killer Cells Therapeutics Market by Therapeutics
10.3.6.5.2 South Korea Natural Killer Cells Therapeutics Market by Application
10.3.6.5.3 South Korea Natural Killer Cells Therapeutics Market by End User
10.3.6.6 Rest of Asia-Pacific Natural Killer Cells Therapeutics Market
10.3.6.6.1 Rest of Asia-Pacific Natural Killer Cells Therapeutics Market by Therapeutics
10.3.6.6.2 Rest of Asia-Pacific Natural Killer Cells Therapeutics Market by Application
10.3.6.6.3 Rest of Asia-Pacific Natural Killer Cells Therapeutics Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Natural Killer Cells Therapeutics Market Overview
10.4.2 Middle East and Africa Natural Killer Cells Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Therapeutics
10.4.4 Middle East and Africa Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Natural Killer Cells Therapeutics Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Natural Killer Cells Therapeutics Market
10.4.6.1.1 South Africa Natural Killer Cells Therapeutics Market by Therapeutics
10.4.6.1.2 South Africa Natural Killer Cells Therapeutics Market by Application
10.4.6.1.3 South Africa Natural Killer Cells Therapeutics Market by End User
10.4.6.2 Saudi Arabia Natural Killer Cells Therapeutics Market
10.4.6.2.1 Saudi Arabia Natural Killer Cells Therapeutics Market by Therapeutics
10.4.6.2.2 Saudi Arabia Natural Killer Cells Therapeutics Market by Application
10.4.6.2.3 Saudi Arabia Natural Killer Cells Therapeutics Market by End User
10.4.6.3 U.A.E Natural Killer Cells Therapeutics Market
10.4.6.3.1 U.A.E Natural Killer Cells Therapeutics Market by Therapeutics
10.4.6.3.2 U.A.E Natural Killer Cells Therapeutics Market by Application
10.4.6.3.3 U.A.E Natural Killer Cells Therapeutics Market by End User
10.4.6.4 Rest of Middle East and Africa Natural Killer Cells Therapeutics Market
10.4.6.4.1 Rest of Middle East and Africa Natural Killer Cells Therapeutics Market by Therapeutics
10.4.6.4.2 Rest of Middle East and Africa Natural Killer Cells Therapeutics Market by Application
10.4.6.4.3 Rest of Middle East and Africa Natural Killer Cells Therapeutics Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Natural Killer Cells Therapeutics Market Overview
10.5.2 South and Central America Natural Killer Cells Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Therapeutics
10.5.4 South and Central America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Application
10.5.5 South and Central America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By End User
10.5.6 South and Central America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Natural Killer Cells Therapeutics Market
10.5.6.1.1 Brazil Natural Killer Cells Therapeutics Market by Therapeutics
10.5.6.1.2 Brazil Natural Killer Cells Therapeutics Market by Application
10.5.6.1.3 Brazil Natural Killer Cells Therapeutics Market by End User
10.5.6.2 Argentina Natural Killer Cells Therapeutics Market
10.5.6.2.1 Argentina Natural Killer Cells Therapeutics Market by Therapeutics
10.5.6.2.2 Argentina Natural Killer Cells Therapeutics Market by Application
10.5.6.2.3 Argentina Natural Killer Cells Therapeutics Market by End User
10.5.6.3 Rest of South and Central America Natural Killer Cells Therapeutics Market
10.5.6.3.1 Rest of South and Central America Natural Killer Cells Therapeutics Market by Therapeutics
10.5.6.3.2 Rest of South and Central America Natural Killer Cells Therapeutics Market by Application
10.5.6.3.3 Rest of South and Central America Natural Killer Cells Therapeutics Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. NATURAL KILLER CELLS THERAPEUTICS MARKET, KEY COMPANY PROFILES
13.1. AFFIMED GMBH
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. FATE THERAPEUTICS
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. GLYCOSTEM
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. INNATE PHARMA, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. NANTKWEST
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. NKARTA, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ZIOPHARM ONCOLOGY, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. NKT THERAPEUTICS, INC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BRIGHTPATH BIOTHERAPEUTICS CO., LTD.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. KUUR THERAPEUTICS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
13.11. CELGENE CORPORATION
13.11.1. Key Facts
13.11.2. Business Description
13.11.3. Products and Services
13.11.4. Financial Overview
13.11.5. SWOT Analysis
13.11.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Affimed N.V.
2. Celgene Corporation
3. Fate Therapeutics
4. Fortress Biotech
5. Glycostem Therapeutics BV
6. Innate Pharma S.A.
7. Nantkwest Inc.
8. Nkarta Therapeutics, Inc.
9. EMERcell
10. Ziopharm Oncology Inc.
TIPRE00015768
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.